Nitrite as regulator of hypoxic signaling in mammalian physiology
- PMID: 19219851
- PMCID: PMC2725214
- DOI: 10.1002/med.20151
Nitrite as regulator of hypoxic signaling in mammalian physiology
Abstract
In this review we consider the effects of endogenous and pharmacological levels of nitrite under conditions of hypoxia. In humans, the nitrite anion has long been considered as metastable intermediate in the oxidation of nitric oxide radicals to the stable metabolite nitrate. This oxidation cascade was thought to be irreversible under physiological conditions. However, a growing body of experimental observations attests that the presence of endogenous nitrite regulates a number of signaling events along the physiological and pathophysiological oxygen gradient. Hypoxic signaling events include vasodilation, modulation of mitochondrial respiration, and cytoprotection following ischemic insult. These phenomena are attributed to the reduction of nitrite anions to nitric oxide if local oxygen levels in tissues decrease. Recent research identified a growing list of enzymatic and nonenzymatic pathways for this endogenous reduction of nitrite. Additional direct signaling events not involving free nitric oxide are proposed. We here discuss the mechanisms and properties of these various pathways and the role played by the local concentration of free oxygen in the affected tissue.
Figures
References
-
- Reichert ET, Mitchell SW. On the physiological action of potassium nitrite. Am J Med Sci. 1880;156:158–180.
-
- Bruningfann C, Kaneene J. The effects of nitrate, nitrite and N-nitroso compounds on human health – a review. Vet Human Toxicol. 1993;35:521– 538. - PubMed
-
- Furchgott R, Bhandrakom S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953;108:129–143. - PubMed
-
- Mittal C, Arnold W, Murad F. Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J Biol Chem. 1978;253:1266–1271. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R37 HL058091/HL/NHLBI NIH HHS/United States
- HL058091/HL/NHLBI NIH HHS/United States
- K02 HL078706/HL/NHLBI NIH HHS/United States
- R01 GM055792/GM/NIGMS NIH HHS/United States
- HL05891/HL/NHLBI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- HL078706/HL/NHLBI NIH HHS/United States
- R29 GM055792/GM/NIGMS NIH HHS/United States
- GM55792/GM/NIGMS NIH HHS/United States
- R29 HL058091/HL/NHLBI NIH HHS/United States
- G0701115/MRC_/Medical Research Council/United Kingdom
- R01 HL058091/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
